Medication info
Glycomin Tablets (Metformin Hydrochloride)

Glycomin Tablets (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
(Ilseong IS Co., Ltd.)
Appearance
White, round, film-coated tablets
Packaging
100 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 199301512 · Notified 1993.08.04 · Insurance code 655400010

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
The dose should be determined individually based on efficacy and tolerability, and should not exceed the recommended maximum daily dose. This medicine must be started at a low dose to reduce gastrointestinal adverse reactions and to identify the minimum dose required for adequate glycemic control. Administer 500mg per dose, 2~3 times daily, with meals. Increase the dose gradually by 500mg each week; when administering up to 2000mg, the dose is usually divided into 2 doses daily, in the morning and evening. For doses greater than 2000mg, divide the dose into 3 administrations daily with meals; the maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess the response to this medicine and identify the minimum effective dose. Measure the blood concentration of glycated hemoglobin at approximately 3-month intervals. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin concentrations to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose blood glucose was controlled by diet alone, short-term administration of this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustments. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to less than 45ml/min or 45ml/min/1.73㎡, respectively, administration of this medicine must be discontinued immediately.
Child dose
Children aged 10 years and older or adolescents who are growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.

Ingredients

Manufacturer
(Ilseong IS Co., Ltd.)

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Insufficient blood sugar control in patients with type 2 diabetes
  • overweight
View approved original text

This medication is used for the management of blood sugar in patients with type 2 diabetes who are not adequately controlled with diet and exercise alone, especially in overweight adult patients. In adults, it can be used alone or in combination with other oral hypoglycemic agents or insulin. It can also be used in children over 10 years of age and adolescents during growth, either as monotherapy or in combination with insulin. This medication helps to effectively control blood sugar, aiding in diabetes management.

How to take

Adult dose

The dose should be determined individually based on efficacy and tolerability, and should not exceed the recommended maximum daily dose. This medicine must be started at a low dose to reduce gastrointestinal adverse reactions and to identify the minimum dose required for adequate glycemic control. Administer 500mg per dose, 2~3 times daily, with meals. Increase the dose gradually by 500mg each week; when administering up to 2000mg, the dose is usually divided into 2 doses daily, in the morning and evening. For doses greater than 2000mg, divide the dose into 3 administrations daily with meals; the maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, measure fasting blood glucose to assess the response to this medicine and identify the minimum effective dose. Measure the blood concentration of glycated hemoglobin at approximately 3-month intervals. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin concentrations to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose blood glucose was controlled by diet alone, short-term administration of this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustments. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate decreases to less than 45ml/min or 45ml/min/1.73㎡, respectively, administration of this medicine must be discontinued immediately.

Child dose

Children aged 10 years and older or adolescents who are growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so caution is needed. Patients with moderate to severe renal impairment, dehydration, serious infections, acute myocardial infarction, or other acute conditions that may affect renal function should not be administered this medication. Avoid use in patients with acute and unstable heart failure or those undergoing examinations using iodinated contrast agents. This medication is contraindicated in patients with hypersensitivity to this drug or to other biguanides, patients with type 1 diabetes, or those with a history of lactic acidosis or diabetic ketoacidosis. Caution is also needed in patients with severe infections, severe traumatic systemic disorders, scheduled surgeries, malnutrition, or frailty, and in those with liver dysfunction. Gastrointestinal side effects are common, especially at the beginning, which may include diarrhea, nausea, vomiting, and abdominal bloating, but usually improve over time. Lactic acidosis is rare but a very serious side effect. If symptoms such as fatigue, muscle pain, difficulty breathing, or abdominal pain occur, medical attention should be sought immediately. Patients with reduced kidney function or the elderly should undergo regular kidney function tests, and this medication should be discontinued if kidney function worsens. The risk of lactic acidosis may increase when taken with alcohol, so excessive drinking should be avoided during treatment. During situations where blood sugar control is difficult, temporary discontinuation of the medication is recommended, with the option of receiving insulin therapy as needed. Patients performing tasks that require alertness, such as operating machinery or driving, need to be aware of the risks of hypoglycemia or lactic acidosis and exercise caution. During pregnancy, this medication crosses the placenta; thus, it should not be used if there is a risk of placental dysfunction or pre-eclampsia. If blood sugar control is necessary during pregnancy, it can be used based on the physician's judgment. During breastfeeding, this medication is excreted in breast milk, so careful consideration of the need for medication treatment while nursing should be made. This medication may interact with multiple drugs, so it is crucial to inform healthcare providers of any other medicines being taken, and blood sugar and kidney function should be monitored regularly. In case of overdose, the drug can be removed through blood dialysis, so medical consultation should be sought immediately after exceeding the dose. This medication does not cause weight gain and may instead assist in weight management. Keep this medication out of the reach of children and do not transfer it to different containers.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver function abnormalities
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture and should be stored in a tightly closed container at room temperature. It should be kept away from direct sunlight and not placed in areas that are too hot or too cold.

Appearance and packaging

Appearance

White, round, film-coated tablets

Package unit

100 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.